Financial Fitness Test

Serb, Chris
June 2006
H&HN: Hospitals & Health Networks;Jun2006, Vol. 80 Issue 6, p34
Trade Publication
The article focuses on the impact of the trend in medical care coverage in the U.S. on the way hospitals get paid for the services they deliver. Tax-advantaged mechanisms are generally coupled with high-deductible, low-premium health insurance polities. Health savings accounts have led to lower employer costs, contributing to their prevalence among consumers. The main concern of hospital organizations lies in the cost-sharing concept behind the insurance polities.


Related Articles

  • cost imperative.  // hfm (Healthcare Financial Management);Apr2008, Vol. 62 Issue 4, p168 

    The article reflects on the state of health insurance and the issue of cost shifting related to it in the U.S. It opines that in the absence of cost shifting, the only alternatives available to deal with price flexibility elimination will be increasing volume and reducing costs. It reflects on...

  • MOMENTUM BUILDS FOR HEALTH REFORM. Wells, Susan J. // HR Magazine;Mar2009, Vol. 54 Issue 3, p38 

    The article stresses the need for U.S. employers to know how health care reform proposals would affect them and alter their roles as of March 2009. It cites approaches adopted by employers to control their annual increases in health expenditures, including shifting more costs to employees and...

  • Debunking Health-Care Myths. Poltenson, Norman // Business Journal (Central New York);8/7/2009, Vol. 23 Issue 32, p16 

    In this article the author debunks some myths associated with medical care in the U.S. He says that one needs to think quality, access, and cost when fixing the health-care system. He emphasizes that the success of Medicare in holding down the health care's growth is a result of cost shifting...

  • Be creative in consumer cost-sharing for pharmaceutical benefits. Swartz, Katherine // Inquiry (00469580);Winter98/99, Vol. 35 Issue 4, p365 

    Recognizes the need for creativity in consumer cost-sharing for pharmaceutical benefits in the United States. Reasons behind the increase in prescription drug spending; Willingness of health insurance companies and managed care plans to shoulder prescription drugs; Role of pharmaceuticals;...

  • A Halfway House to Universal Care. Kuttner, Robert // BusinessWest;11/21/2011, p12 

    The author focuses on the pursuit on a brand of reform built on insurance system by U.S. President Barack Obama, which has opted for a strategy which increases complexity and administrative cost and respond to fiscal pressures by shifting costs to patients and doctors in the U.S.

  • Strategies weighed to slow health spending.  // AHA News;2/5/2007, Vol. 43 Issue 3, p6 

    The reports that the strategies of the U.S. government to stop health care spending growth will not improve overall health system performance, according to the Commonwealth Fund report. The report particularly pinpoints strategies that focus on one aspect of health care or shift expenditures...

  • US health spending up; medicare expanded. Catton, Michelle // CMAJ: Canadian Medical Association Journal;6/7/2005, Vol. 172 Issue 12, p1545 

    Focuses on the increase in health spending in the U.S. as of June 2005. Projection of the total health spending by 2014; Factors which contributed to the health spending increase; Purpose of legislation on prescription drug coverage.

  • Health plan regulation is state domain: NAIC. Fletcher, Meg // Business Insurance;03/31/97, Vol. 31 Issue 13, p3 

    Reports that it is the opinion of state insurance regulators in the United States that individual states should regulate any risk bearing entity covering the cost of health care. Details on the concerns of state insurance regulators; Measures taken by regulators to enforce their opinions;...

  • Transferring the costs of expensive treatments from secondary to primary care. Crump, B.J.; Panton, R. // BMJ: British Medical Journal (International Edition);2/25/95, Vol. 310 Issue 6978, p509 

    Discusses the practice of transferring the costs of expensive treatments from secondary to primary care or cost shifting among general practitioners. Funding of drug expenditure; Options for funding mechanisms; Stimulating adequate assessments.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics